Literature DB >> 22523622

Indications for endoscopy according to the revised FIGO staging for cervical cancer after MRI and CT scanning.

Bae Kwon Jeong1, Seung Jae Huh, Doo Ho Choi, Won Park, Dongryul Oh, Taegyu Kim, Hye Bin Lee.   

Abstract

OBJECTIVE: A recent revision of the FIGO staging system does not recommend the mandatory use of cystoscopy and sigmoidoscopy. The objective of this study was to assess the clinical utility of CT or MRI scans for ruling out bladder or rectal invasion and determine the indication for endoscopy in patients with cervical cancer.
METHODS: We retrospectively reviewed 769 patients with cervical cancer, who underwent imaging and endoscopic work-up between January 1997 and December 2010. Using endoscopy as the standard reference for comparison, we calculated the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of the imaging modality for bladder or rectal invasion.
RESULTS: The CT scan showed 68.2% and 85.7% for sensitivity and 96.4% and 98.9% for specificity in detecting bladder and rectal invasion, respectively. CT scan provided a low PPV (51.7%, 54.5%) and a high NPV (98.2%, 99.8%). MRI scan showed 88.0% and 75.0% for sensitivity and 93.1% and 98.9% for specificity in detecting bladder and rectal invasion, respectively. MRI scan provided a low PPV (35.6%, 42.9%) and a high NPV (99.4%, 99.7%). The accuracies of CT and MRI scans in identifying bladder invasion were 94.9% and 92.8%, respectively. The accuracies of CT and MRI in identifying rectal invasion were 98.7% and 98.6%, respectively.
CONCLUSION: The results of this study demonstrate that additional invasive endoscopy is not necessary for patients who present with no invasion on imaging work-up, and therefore, endoscopy should be considered a tool for confirming cases that are positive for invasion based on imaging work-up.

Entities:  

Keywords:  Computed tomography; Cystoscopy; Magnetic resonance imaging; Sigmoidoscopy; Uterine cervical neoplasms

Year:  2012        PMID: 22523622      PMCID: PMC3325353          DOI: 10.3802/jgo.2012.23.2.80

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  17 in total

1.  Prognostic significance of MRI-detected bladder muscle and/or serosal invasion in patients with cervical cancer treated with radiotherapy.

Authors:  H Nam; S J Huh; W Park; D S Bae; B G Kim; J H Lee; C K Kim; B K Park
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

2.  Revised FIGO staging for carcinoma of the cervix.

Authors:  Sergio Pecorelli; Lucia Zigliani; Franco Odicino
Journal:  Int J Gynaecol Obstet       Date:  2009-04-01       Impact factor: 3.561

3.  Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.

Authors:  Hedvig Hricak; Constantine Gatsonis; Dennis S Chi; Marco A Amendola; Kathy Brandt; Lawrence H Schwartz; Susan Koelliker; Evan S Siegelman; Jeffrey J Brown; Robert B McGhee; Revathy Iyer; Kenneth M Vitellas; Bradley Snyder; Harry J Long; James V Fiorica; Donald G Mitchell
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

4.  Comparison of diagnostic studies in the pretreatment evaluation of stage Ib carcinoma of the cervix.

Authors:  H Hricak; K K Yu; C B Powell; L L Subak; J Stem; R L Arenson
Journal:  Acad Radiol       Date:  1996-04       Impact factor: 3.173

5.  Assessing disease extent in women with bulky or clinically evident metastatic cervical cancer: yield of pretreatment studies.

Authors:  L S Massad; C Calvello; S H Gilkey; N R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2000-03       Impact factor: 5.482

6.  Staging of cervical carcinoma: accuracy of magnetic resonance imaging and computed tomography.

Authors:  C L Janus; D S Mendelson; S Moore; E S Gendal; P Dottino; M Brodman
Journal:  Clin Imaging       Date:  1989-06       Impact factor: 1.605

7.  Invasive cervical carcinoma: comparison of MR imaging and surgical findings.

Authors:  H Hricak; C G Lacey; L G Sandles; Y C Chang; M L Winkler; J L Stern
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

8.  Revisiting the role of computerized tomographic scan and cystoscopy for detecting bladder invasion in the revised FIGO staging system for carcinoma of the uterine cervix.

Authors:  Daya Nand Sharma; Sanjay Thulkar; Shikha Goyal; Nootan Kumar Shukla; Sunesh Kumar; Goura Kisor Rath; Parmod Kumar Julka; Gagan Saini; Amit Bahl
Journal:  Int J Gynecol Cancer       Date:  2010-04       Impact factor: 3.437

9.  Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings.

Authors:  H Hawighorst; S O Schoenberg; P G Knapstein; M V Knopp; U Schaeffer; M Essig; G van Kaick
Journal:  J Comput Assist Tomogr       Date:  1998 Jan-Feb       Impact factor: 1.826

Review 10.  Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging.

Authors:  L L Subak; H Hricak; C B Powell; L Azizi; J L Stern
Journal:  Obstet Gynecol       Date:  1995-07       Impact factor: 7.661

View more
  3 in total

1.  The feasibility of reduced field-of-view diffusion-weighted imaging in evaluating bladder invasion of uterine cervical cancer.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Masafumi Harada
Journal:  Br J Radiol       Date:  2021-10-27       Impact factor: 3.039

2.  Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction.

Authors:  Zhi-Jian Lin; Hong-Yan Qiu; Xiao-Xin Tong; Yi Guo; Man-Fu Han; Chun-Shui Yang; Kai-Hua Lin; Jun Wu; Xing Li; Yang Yang
Journal:  Biosci Rep       Date:  2018-01-17       Impact factor: 3.840

3.  The role and significance of magnetic resonance imaging and miRNA-125b expression level in diagnosis of head and neck squamous cell carcinoma.

Authors:  Qibiao Huang; Xiao Zhang; Biao Gong; Dongquan Ge
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.